Novel parameter for cancer chemosensitivity to fibroblast growth factor receptor inhibitors.
Saved in:
| Title: | Novel parameter for cancer chemosensitivity to fibroblast growth factor receptor inhibitors. |
|---|---|
| Authors: | Kitano S; iACT-Colon Cancer Project, Kyoto University Hospital, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yamamoto T; iACT-Colon Cancer Project, Kyoto University Hospital, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Medical Research Institute, Kitano Hospital, Osaka, Japan., Taketo MM; iACT-Colon Cancer Project, Kyoto University Hospital, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Medical Research Institute, Kitano Hospital, Osaka, Japan. |
| Source: | Cancer science [Cancer Sci] 2022 Nov; Vol. 113 (11), pp. 4005-4010. Date of Electronic Publication: 2022 Aug 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
